52% of the semaglutide-treated test subjects achieved a weight loss response of greater than 5%, while a weight loss response of greater than 10% was achieved by 21% of the test subjects treated with the peptide
You dissolve it under your tongue daily rather than injecting weekly
These appointments provide opportunities to adjust management strategies, address emerging concerns, and reinforce adherence
During this phase, the goal shifts from active weight loss to preserving results, supporting insulin sensitivity, and maintaining long term metabolic health
Evidence indicates that when used alongside a balanced diet, physical activity, and clinical support, Wegovy users taking Wegovy 7.2mg lost an average of 20.7% of their body weight over 72 weeks
Epigenetic germline inheritance of diet-induced obesity and insulin resistance